106 related articles for article (PubMed ID: 9688697)
1. Liposomal VIP attenuates phenylephrine- and ANG II-induced vasoconstriction in vivo.
Ikezaki H; Onyüksel H; Rubinstein I
Am J Physiol; 1998 Aug; 275(2):R588-95. PubMed ID: 9688697
[TBL] [Abstract][Full Text] [Related]
2. Vasodilation elicited by liposomal VIP is unimpeded by anti-VIP antibody in hamster cheek pouch.
Ikezaki H; Paul S; Alkan-Onyüksel H; Patel M; Gao XP; Rubinstein I
Am J Physiol; 1998 Jul; 275(1):R56-62. PubMed ID: 9688960
[TBL] [Abstract][Full Text] [Related]
3. Exogenous calmodulin potentiates vasodilation elicited by phospholipid-associated VIP in vivo.
Ikezaki H; Patel M; Onyüksel H; Akhter SR; Gao XP; Rubinstein I
Am J Physiol; 1999 May; 276(5):R1359-65. PubMed ID: 10233028
[TBL] [Abstract][Full Text] [Related]
4. Mechanisms of vasodilation elicited by VIP in sterically stabilized liposomes in vivo.
Séjourné F; Suzuki H; Alkan-Onyüksel H; Gao XP; Ikezaki H; Rubinstein I
Am J Physiol; 1997 Jul; 273(1 Pt 2):R287-92. PubMed ID: 9249562
[TBL] [Abstract][Full Text] [Related]
5. Encapsulation of VIP into liposomes restores vasorelaxation in hypertension in situ.
Suzuki H; Noda Y; Gao XP; Séjourné F; Alkan-Onyuksel H; Paul S; Rubinstein I
Am J Physiol; 1996 Jul; 271(1 Pt 2):H282-7. PubMed ID: 8760186
[TBL] [Abstract][Full Text] [Related]
6. All D-VIP mitigates vasodilation elicited by L-VIP, micellar L-VIP and micellar PACAP1-38, but not PACAP1-38, in vivo.
Rubinstein I; Ashok B; Tsueshita T; Onyüksel H
Peptides; 2005 Mar; 26(3):509-15. PubMed ID: 15652658
[TBL] [Abstract][Full Text] [Related]
7. Activation of thromboxane receptors and the induction of vasomotion in the hamster cheek pouch microcirculation.
Verbeuren TJ; Vallez MO; Lavielle G; Bouskela E
Br J Pharmacol; 1997 Nov; 122(5):859-66. PubMed ID: 9384501
[TBL] [Abstract][Full Text] [Related]
8. Conformation and vasoreactivity of VIP in phospholipids: effects of calmodulin.
Rubinstein I; Patel M; Ikezaki H; Dagar S; Onyüksel H
Peptides; 1999 Dec; 20(12):1497-501. PubMed ID: 10698126
[TBL] [Abstract][Full Text] [Related]
9. Stable VIP analogue Ro-24-9981 potentiates substance P-induced plasma exudation in hamster cheek pouch.
Gao XP; Jaffe HA; Olopade CO; Rubinstein I
J Appl Physiol (1985); 1995 Sep; 79(3):968-74. PubMed ID: 8567541
[TBL] [Abstract][Full Text] [Related]
10. Acute infusion of nicotine potentiates norepinephrine-induced vasoconstriction in the hamster cheek pouch.
Mayhan WG
J Lab Clin Med; 1999 Jan; 133(1):48-54. PubMed ID: 10385481
[TBL] [Abstract][Full Text] [Related]
11. Differential involvement of the arachidonic acid cascade on the alpha 1-adrenergic potentiation of vasoactive intestinal peptide- versus beta-adrenergic-stimulated cyclic AMP and cyclic GMP accumulation in rat pinealocytes.
Chik CL; Young I; Ho AK
J Neurochem; 1991 Nov; 57(5):1534-9. PubMed ID: 1655977
[TBL] [Abstract][Full Text] [Related]
12. Neutral endopeptidase modulates VIP-induced vasodilation in hamster cheek pouch vessels in situ.
Suzuki H; Gao XP; Olopade CO; Rubinstein I
Am J Physiol; 1996 Aug; 271(2 Pt 2):R393-7. PubMed ID: 8770140
[TBL] [Abstract][Full Text] [Related]
13. Homocellular conduction along endothelium and smooth muscle of arterioles in hamster cheek pouch: unmasking an NO wave.
Budel S; Bartlett IS; Segal SS
Circ Res; 2003 Jul; 93(1):61-8. PubMed ID: 12791708
[TBL] [Abstract][Full Text] [Related]
14. Encapsulation of vasoactive intestinal peptide into liposomes: effects on vasodilation in vivo.
Suzuki H; Noda Y; Paul S; Gao XP; Rubinstein I
Life Sci; 1995; 57(15):1451-7. PubMed ID: 7674836
[TBL] [Abstract][Full Text] [Related]
15. Liposomal VIP potentiates DNA synthesis in cultured oral keratinocytes.
Rubinstein I; Dagar S; Sethi V; Krishnadas A; Onyüksel H
Peptides; 2001 Apr; 22(4):671-5. PubMed ID: 11311738
[TBL] [Abstract][Full Text] [Related]
16. Longchain n-3 polyunsaturated fatty acids and microvascular reactivity: observation in the hamster cheek pouch.
Conde CM; Cyrino FZ; Bottino DA; Gardette J; Bouskela E
Microvasc Res; 2007 May; 73(3):237-47. PubMed ID: 17196224
[TBL] [Abstract][Full Text] [Related]
17. Effects of peptide molecular mass and PEG chain length on the vasoreactivity of VIP and PACAP(1-38) in pegylated phospholipid micelles.
Ashok B; Rubinstein I; Tsueshita T; Onyüksel H
Peptides; 2004 Aug; 25(8):1253-8. PubMed ID: 15350692
[TBL] [Abstract][Full Text] [Related]
18. Liposomal vasoactive intestinal peptide.
Sethi V; Onyüksel H; Rubinstein I
Methods Enzymol; 2005; 391():377-95. PubMed ID: 15721392
[TBL] [Abstract][Full Text] [Related]
19. Effects of a calcium antagonist and of the adrenergic system on spontaneous vasomotion and mean arteriolar diameter in the hamster cheek pouch: influence of buflomedil.
Bouskela E; Cyrino FZ
Int J Microcirc Clin Exp; 1997; 17(4):164-74. PubMed ID: 9378566
[TBL] [Abstract][Full Text] [Related]
20. Interactions of VIP with rigid phospholipid bilayers: implications for vasoreactivity.
Onyüksel H; Ashok B; Dagar S; Sethi V; Rubinstein I
Peptides; 2003 Feb; 24(2):281-6. PubMed ID: 12668213
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
